Sensitivity of cell lines to mitomycin C

British Journal of Urology

Volumn 77, Issue 3, 1996, Pages 363-366

  Watts, P L ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bladder carcinoma; Cell culture; Cytotoxicity; Mitomycin C; pH

Indexed keywords

MITOMYCIN C;

ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CYTOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; TISSUE CULTURE CELL;

EID: 0029875936     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.09017.x     Document Type: Article

References (18)

1. Harrison GSM. Green DF. Newling DWW. Richards B, Robinson MRG, Smith PH. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. BrJUrol 1983: 55: 1676-9
2. Sommerville JJF. Newling DWW. Richards B. Robinson MRG, Smith PH. Mitomycin C in superficial bladder cancer: 24 week follow-up. BrJ Urol 1985: 57: 586-9
3. Hetherington JW. Newling DWW, Robinson MRG. Smith PH. Adib RS, Whelan P. Intravesical mitomycin C for the treatment of recent superficial bladder tumours. Br JUrol 1987: 59: 239-41
4. Beretta G. Cartel G. Giraldi T. Mitomycin C-Pharmacology and Clinical Uses. Turin: Minerva Medica Publishers. 1990: 34-44
5. Tolley DA. Hargreave TB. Smith PH, et al. Effect of mitomycin C on the recurrence of newly diagnosed superficial bladder cancer: An interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Centre Working Party), Br Med J1988; 296: 1759-61
6. Hamdy FC. Hastie KJ, Kerry R. Williams JL. Mitomycin C in superficial bladder cancer: Is long-term maintenance therapy worthwhile? BrJUral 1993: 71: 183-6
7. Walker MC, Masters JRW. Parris CN. Hepburn P], English Pf. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity. Urol Res 1985; 14: 137-40
8. Bracken RB. Mitomycin C in superficial bladder cancer. In Ogawa M, Rozencweig M. Staquet MJeds. Mitomycin C. Amsterdam: Excerpta Medica 1. 1982: 135-42
9. Groos E, Walker L, Masters JRW. Intravesical chemotherapy: studies on the relationship between pH and cytotoxicity. Cancer 1986; 58: 1199-203
10. Kennedy KA, McGurl JD, Leondaridis L, Alabaster O. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumour cells. Cancer Res 1986; 45: 3541-7
11. O'Toole CM. Povey S, Hepburn P, Franks LM. Identity of some human bladder cancer cell lines. Nature 1983; 301: 429-30
12. Walker MC, Povey S. Parrington JM, Riddle PN. Knuechel R. Masters JRW. Development and characterisation of cisplatin-resistant human testicular and bladder tumour cell lines. Eur J Cancer 1990; 26: 742-7
13. Twentyman PR. Fox ME. Wright KA et al. The in vitro effects and cross-resistance patterns of some novel anthrocyclines. Br J Cancer 1986: 53: 585
14. Plumb JA. Milroy R, Kaye SB. Effects of the pH dependence of 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium based assay. Cancer Res 1989; 49:4435-40
15. Plumb JA, Workman P. Unusually marked hypoxic sensitization of indoloquinine E09 and mitomycin C in a human colon tumour cell line that lacks DT-diaphorase activity. IntJCancer 1994; 56: 134-9
16. Siegel D, Gibson NW, Preusch PC. Ross D. Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 1990; 50: 7483-9
17. Vaupel P, Kallenowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumours. A review. Cancer Res 1989; 49: 6449-65
18. Riley RJ, Workman P. DT-Diaphorase and cancer chemotherapy. Biochem Pharmacol 1992: 43: 1657-69